MedTrace Logo

Protective Efficacy of HPV Vaccination After Treatment of HPV Related Diseases

NCT05085093 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 414

Last updated 2021-10-20

No results posted yet for this study

Summary

To understand the HPV infection status and subtype distribution of patients, and to study the protective effect of prophylactic HPV vaccination on the recurrence of HPV related diseases after treatment through a prospective cohort study. To provide data support for the primary prevention of HPV related diseases in Chinese women after treatment, and to analyze the related factors of HPV related disease recurrence and HPV continuous positive.

Conditions

  • HPV Vaccination、HPV Related Diseases、Protective Efficacy

Interventions

BIOLOGICAL

HPV vaccine

Patients choose to be vaccinated or not to be vaccinated with HPV vaccine according to their own wishes

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • hong Yang, professional · The First Affiliated Hospital，Air Force Medical University,Xi'an, Shaanxi, China

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-18
Primary Completion
2022-03-01
Completion
2024-09-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05085093 on ClinicalTrials.gov